AdvancedAdvT Ltd.LSE: ADVT

AdvancedAdvT: Purchase of Own Shares

· Issued by AdvancedAdvT Ltd. via RNS

Summary by 6ix AI

AdvancedAdvT Limited, an international software provider for the business solutions, healthcare compliance and human capital management sectors, bought 552,000 of its ordinary shares from October 12, 2026 up to and including October 16, 2026, following its confirmed intention to renew its share buyback programme. The shares will be held in treasury, meaning the company keeps them.

Key details

  • Prices paid were 185.000 pence per share on each day from October 12 to October 15, 2026, and 183.000 pence per share on October 16, 2026.
  • Daily purchases were 52,000 shares on October 12, 100,000 on October 13, 150,000 on October 14, 100,000 on October 15 and 150,000 on October 16, 2026, all on the AIMX trading venue.
  • The cumulative number of shares bought under the company's buyback programmes since March 4, 2026 is 7,461,453.
  • Following the purchase, total issued share capital will consist of 137,125,806 ordinary shares, of which 7,461,453 are held in treasury, leaving 129,664,353 shares carrying voting rights. Shareholders may use this figure to work out whether they must notify their interest in the company under UK disclosure rules.

6ix AI wrote this summary from the release below and checked it against the release.

AdvancedAdvT Limited
19 October 2026
 

This announcement contains inside information
for the purposes of UK Market Abuse Regulation.

19 October 2026

AdvancedAdvT Limited

Purchase of Own Shares

AdvancedAdvT Limited (AIM: ADVT, “AdvT”, the “Group”, the “Company”), the international software solutions provider for the business solutions, healthcare compliance, and human capital management sectors, announces that further to the confirmation of its intention to renew its share buyback programme, as set out in its announcement on 16 September 2026, in the period from 12 October 2026 up to and including 16 October 2026, it purchased a further 552,000 of its ordinary shares of no par value in the capital of the Company (“Ordinary Shares”). The Ordinary Shares purchased will be held in treasury.

Following this purchase, the cumulative number of Ordinary Shares purchased under the Company’s buyback programmes since 4 March 2026 is 7,461,453.

Aggregated information

Date of purchase

Number of Ordinary Shares purchased

Highest price paid per Ordinary Share

Lowest price paid per Ordinary Share

Volume Weighted price paid per Ordinary Share

12 October 2026

52,000

 185.000p

 185.000p

 185.000p

13 October 2026

100,000

 185.000p

 185.000p

 185.000p

14 October 2026

150,000

 185.000p

 185.000p

 185.000p

15 October 2026

100,000

 185.000p

 185.000p

 185.000p

16 October 2026

150,000

 183.000p

 183.000p

 183.000p

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018), a detailed breakdown of individual trades is available below:

Date of purchase

Number of Ordinary Shares purchased

Transaction price

Time of transaction

Trading venue

 12 October 2026

52,000

185.000p

08:56

AIMX

 13 October 2026

100,000

185.000p

08:52

AIMX

 14 October 2026

150,000

185.000p

09:45

AIMX

 15 October 2026

20,000

185.000p

08:33

AIMX

 15 October 2026

80,000

185.000p

12:11

AIMX

 16 October 2026

150,000

183.000p

10:35

AIMX

Total voting rights

Following the purchase, the Company's total issued share capital will consist of 137,125,806 Ordinary Shares each carrying one voting right, of which 7,461,453 Ordinary Shares are held in treasury. Therefore, the total number of Ordinary Shares carrying voting rights will be 129,664,353. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The person responsible for arranging the release of this Announcement
on behalf of the Company is Gavin Hugill, Chief Financial Officer.

Enquiries:

AdvancedAdvT Limited

Vin Murria, Chairperson

Gavin Hugill, Chief Financial Officer

Singer Capital Markets (Nominated Adviser and Broker)

Tel: 020 7496 3000

James Moat / James Fischer

KK Advisory (Investor Relations)

Tel: 020 7039 1901

Kam Bansil 

Note to Editors

AdvancedAdvT Limited (AdvT) provides software solutions and platforms across two business transformational areas: business solutions & healthcare compliance, and human capital management.

AdvT is an agent for change. The Group enables the delivery of Artificial Intelligence ("AI"), data analytics and business intelligence, all of which are key future drivers for growth in those sectors where long term digitisation trends are set to transform the workplace for professionals. 

AdvT is developing both organically and through acquisitions, by expanding its presence across adjacent markets, geographical boundaries and digital sectors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

AdvancedAdvT Ltd. on 6ix

Earlier from AdvancedAdvT

All AdvancedAdvT news releases